Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study.

To assess the risk of lung cancer in patients with chronic obstructive pulmonary disease, we matched, on the basis of age, sex, occupation, and smoking history, 113 persons ("cases") who had a forced expiratory volume in 1 second (FEV1) of 70% or less of predicted normal with 113 control persons who had an FEV1 of 85% or more. All persons were observed from 1973-74 through 1984 for a diagnosis of lung cancer, death from lung cancer, and death from any cause. At entry, subjects had an age range of 45 to 59 years; men numbered 186 and women 40. Histologically proven lung cancer developed in 9 cases and in 2 controls, all men. The rate of development of lung cancer was significantly different in the two groups (p = 0.024): the 10-year cumulative percentage was 8.8% for cases and 2.0% for controls. Overall 10-year survival was estimated to be 74.0% for cases and 91.1% for controls (p less than 0.001).

[1]  M. Kuschner.  The J. Burns Amberson Lecture. The causes of lung cancer. , 1968 .

[2]  J. R. Landis,et al.  An index of risk for obstructive airways disease. , 2015, The American review of respiratory disease.

[3]  K. Offord,et al.  Host factors in chronic obstructive pulmonary disease in an upper Midwest rural community. Design, case selection, and clinical characteristics in a matched-pair study. , 1976, Mayo Clinic proceedings.

[4]  B. Ferris,et al.  PREDICTION VALUES FOR SCREENING TESTS OF PULMONARY FUNCTION. , 2015, The American review of respiratory disease.

[5]  R. V. Lourenço,et al.  Deposition and clearance of 2 micron particles in the tracheobronchial tree of normal subjects--smokers and nonsmokers. , 1971, The Journal of clinical investigation.

[6]  D. Massaro,et al.  Idiopathic diffuse interstitial pulmonary fibrosis (fibrosing alveolitis), atypical epithelial proliferation and lung cancer. , 1968, The American journal of medicine.

[7]  R. Loddenkemper,et al.  Patterns of distribution and clearance of aerosols in patients with bronchiectasis. , 2015, The American review of respiratory disease.

[8]  E. C. Hammond,et al.  Asbestos exposure, smoking, and neoplasia. , 1968, JAMA.

[9]  A. Fraire,et al.  Carcinoma and diffuse interstitial fibrosis of lung , 1973, Cancer.

[10]  T H Beaty,et al.  Impaired pulmonary function as a risk factor for mortality. , 1982, American journal of epidemiology.

[11]  N Mantel,et al.  Ranking procedures for arbitrarily restricted observation. , 1967, Biometrics.

[12]  B. Burrows,et al.  Predictors of mortality in chronic obstructive pulmonary disease. A 15-year follow-up study. , 1979, The American review of respiratory disease.

[13]  S. Permutt,et al.  A COMMON FAMILIAL COMPONENT IN LUNG CANCER AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE , 1977, The Lancet.

[14]  H. Sluiter,et al.  Cancer and chronic non-specific lung disease (C.N.S.L.D.). , 1966, Scandinavian journal of respiratory diseases.

[15]  J. Hankinson,et al.  Time-pulse generator for flow-volume curves. , 1970, Journal of applied physiology.

[16]  F. Speizer,et al.  The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation. , 1983, The American review of respiratory disease.

[17]  W. Foster,et al.  Measurement of tracheal and bronchial mucus velocities in man: relation to lung clearance. , 1980, Journal of applied physiology: respiratory, environmental and exercise physiology.

[18]  A. Davis.  Bronchogenic Carcinoma in Chronic Obstructive Pulmonary Disease , 1976 .

[19]  D. Cox.  Regression Models and Life-Tables , 1972 .